Skip to main content
Caplight Logo









Genbioma Aplicaciones

Genbioma Aplicaciones

Private
SpainHealthcare & Life Scienceshttps://genbioma.com/

Last Round

Series A

Sep 1, 2025

Total Funding Raised

$997,000

Company Overview

Genbioma Aplicaciones is a biotechnology company that develops probiotic and postbiotic ingredients to regulate blood glucose levels and manage metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

postbioticsprobioticsmetabolic healthmicrobiome researchfunctional ingredientsheat-inactivated postbioticsgut healthnutraceuticalsglucose controlmetagenomicsmetabolomicsbiotech ingredientsstrain screeningnext-gen probioticsR&D platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genbioma Aplicaciones Comparables

Compare Genbioma Aplicaciones with similar companies based on industry and business-model similarity.

Genbioma Aplicaciones comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Postbiotica S.r.l.
77%
ROELMI HPC
77%
ADM
74%

Genbioma Aplicaciones Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 1, 2025
SeedFeb 11, 2025
VC RoundDec 1, 2024
VC RoundJan 26, 2021
SeedFeb 6, 2020

Key People

Founding team and executive leadership

Miguel Angel Barajas Velez

Socio Co-fundador CTO

Executive Team

Genbioma Aplicaciones Investors

Notable investors and investment history

Genbioma Aplicaciones investors
InvestorRounds
Clave CapitalSeed, VC Round
Women Angels for STEAMVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    $2.1M round completed.

  • Dec 1, 2024

    $549K round led by Clave Capital.

Genbioma Aplicaciones Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genbioma Aplicaciones Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genbioma Aplicaciones's valuation, stock price, and market status.

Firmographic Details

HeadquartersSpain
Employee Range10
Year Founded2019
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?